| [1] |
Jiang X, Liu B, Nie Z, et al. The role of m6A modification in the biological functions and diseases[J]. Signal Transduct Target Ther, 2021, 6(1):74.
|
| [2] |
Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications[J]. Nat Rev Mol Cell Biol, 2017, 18(1):31-42.
|
| [3] |
Meyer KD, Saletore Y, Zumbo P, et al. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons[J]. Cell, 2012, 149(7):1635-1646.
|
| [4] |
Zheng G, Dahl JA, Niu Y, et al. ALKBH5 is a mammalian RNA demethylase that impacts RNA metabolism and mouse fertility[J]. Mol Cell, 2013, 49(1):18-29.
|
| [5] |
Wang X, Feng J, Xue Y, et al. Structural basis of N(6)-adenosine methylation by the METTL3-METTL14 complex[J]. Nature, 2016, 534(7608):575-578.
|
| [6] |
Ping XL, Sun BF, Wang L, et al. Mammalian WTAP is a regulatory subunit of the RNA N6-methyladenosine methyltransferase[J]. Cell Res, 2014, 24(2):177-189.
|
| [7] |
Schwartz S, Mumbach MR, Jovanovic M, et al. Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites[J]. Cell Rep, 2014, 8(1):284-296.
|
| [8] |
Patil DP, Chen CK, Pickering BF, et al. m(6)A RNA methylation promotes XIST-mediated transcriptional repression[J]. Nature, 2016, 537(7620):369-373.
|
| [9] |
Xiang Y, Laurent B, Hsu CH, et al. RNA m6A methylation regulates the ultraviolet-induced DNA damage response[J]. Nature, 2017, 543(7646):573-576.
|
| [10] |
Dina C, Meyre D, Gallina S, et al. Variation in FTO contributes to childhood obesity and severe adult obesity[J]. Nat Genet, 2007, 39(6):724-726.
|
| [11] |
Su R, Dong L, Li C, et al. R-2HG exhibits anti-tumor activity by targeting FTO/m6A/MYC/CEBPA signaling[J]. Cell, 2018, 172(1/2): 90-105, e23.
|
| [12] |
Mauer J, Luo X, Blanjoie A, et al. Reversible methylation of m6Am in the 5' cap controls mRNA stability[J]. Nature, 2017, 541(7637): 371-375.
|
| [13] |
Mauer J, Sindelar M, Despic V, et al. FTO controls reversible m6Am RNA methylation during snRNA biogenesis[J]. Nat Chem Biol, 2019, 15(4):340-347.
|
| [14] |
Linder B, Grozhik AV, Olarerin-George AO, et al. Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome[J]. Nat Methods, 2015, 12(8):767-772.
|
| [15] |
Xiao W, Adhikari S, Dahal U, et al. Nuclear m(6)A reader YTHDC1 regulates mRNA splicing[J]. Mol Cell, 2016, 61(4):507-519.
|
| [16] |
Hsu PJ, Zhu Y, Ma H, et al. Ythdc2 is an N(6)-methyladenosine binding protein that regulates mammalian spermatogenesis[J]. Cell Res, 2017, 27(9):1115-1127.
|
| [17] |
Shi H, Wang X, Lu Z, et al. YTHDF3 facilitates translation and decay of N(6)-methyladenosine-modified RNA[J]. Cell Res, 2017, 27(3):315-328.
|
| [18] |
Xie W, Ma LL, Xu YQ, et al. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism[J]. Biochem Biophys Res Commun, 2019, 518(1):120-126.
|
| [19] |
Hou J, Zhang H, Liu J, et al. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma[J]. Mol Cancer, 2019, 18(1):163.
|
| [20] |
Kessler SM, Laggai S, Barghash A, et al. IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype[J]. Cell Death Dis, 2015(6):e1894.
|
| [21] |
Huang H, Weng H, Sun W, et al. Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation[J]. Nat Cell Biol, 2018, 20(3):285-295.
|
| [22] |
Imam H, Khan M, Gokhale NS, et al. N6-methyladenosine modification of hepatitis B virus RNA differentially regulates the viral life cycle[J]. Proc Natl Acad Sci U S A, 2018, 115(35):8829-8834.
|
| [23] |
Gokhale NS, Mcintyre ABR, Mcfadden MJ, et al. N6-methyladenosine in flaviviridae viral RNA genomes regulates infection[J]. Cell Host Microbe, 2016, 20(5):654-665.
|
| [24] |
Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2018, 68(6): 394-424.
|
| [25] |
Ma JZ, Yang F, Zhou CC, et al. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N(6)-methyladenosine-dependent primary MicroRNA processing[J]. Hepatology, 2017, 65(2):529-543.
|
| [26] |
Han B, Chu C, Su X, et al. N(6)-methyladenosine-dependent primary microRNA-126 processing activated PI3K-AKT-mTOR pathway drove the development of pulmonary fibrosis induced by nanoscale carbon black particles in rats[J]. Nanotoxicology, 2020, 14(1):1-20.
|
| [27] |
Chen M, Wei L, Law CT, et al. RNA N6-methyladenosine methyltransferase-like 3 promotes liver cancer progression through YTHDF2-dependent posttranscriptional silencing of SOCS2[J]. Hepatology, 2018, 67(6):2254-2270.
|
| [28] |
Chen Y, Peng C, Chen J, et al. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1[J]. Mol Cancer, 2019, 18(1):127.
|
| [29] |
Li J, Zhu L, Shi Y, et al. m6A demethylase FTO promotes hepatocellular carcinoma tumorigenesis via mediating PKM2 demethylation[J]. Am J Transl Res, 2019, 11(9):6084-6092.
|
| [30] |
Zhao X, Chen Y, Mao Q, et al. Overexpression of YTHDF1 is associated with poor prognosis in patients with hepatocellular carcinoma[J]. Cancer Biomark, 2018, 21(4):859-868.
|
| [31] |
Gutschner T, Hammerle M, Pazaitis N, et al. Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) is an important protumorigenic factor in hepatocellular carcinoma[J]. Hepatology, 2014, 59(5):1900-1911.
|
| [32] |
Jo HJ, Shim HE, Han ME, et al. WTAP regulates migration and invasion of cholangiocarcinoma cells[J]. J Gastroenterol, 2013, 48(11):1271-1282.
|
| [33] |
Rong ZX, Li Z, He JJ, et al. Downregulation of fat mass and obesity associated (FTO) promotes the progression of intrahepatic cholangiocarcinoma[J]. Front Oncol, 2019(9):369.
|
| [34] |
Lin X, Chai G, Wu Y, et al. RNA m6A methylation regulates the epithelial mesenchymal transition of cancer cells and translation of Snail[J]. Nat Commun, 2019, 10(1):2065.
|
| [35] |
Peng S, Xiao W, Ju D, et al. Identification of entacapone as a chemical inhibitor of FTO mediating metabolic regulation through FOXO1[J]. Sci Transl Med, 2019, 11(488):eaau7116.
|
| [36] |
Huang Y, Yan J, Li Q, et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5[J]. Nucleic Acids Res, 2015, 43(1):373-384.
|
| [37] |
Cui Q, Shi H, Ye P, et al. m6A RNA methylation regulates the self-renewal and tumorigenesis of glioblastoma stem cells[J]. Cell Rep, 2017, 18(11):2622-2634.
|
| [38] |
Yang S, Wei J, Cui YH, et al. m6A mRNA demethylase FTO regulates melanoma tumorigenicity and response to anti-PD-1 blockade[J]. Nat Commun, 2019, 10(1):2782.
|
| [39] |
Han D, Liu J, Chen C, et al. Anti-tumour immunity controlled through mRNA m6A methylation and YTHDF1 in dendritic cells[J]. Nature, 2019, 566(7743):270-274.
|